 |  |  |
Callera GE, Touyz RM, Tostes RC, Yogi A, He Y, Malkinson S, and Schiffrin EL
| |
Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src.
| |
Hypertension
|
45(4):773-779, 2005.
|
|
|
 |  |  | Abbott KL, Archambault J, Xiao H, Nguyen BD, Roeder RG, Greenblatt J, Omichinski JG, Legault P | |
Interactions of the HIV-1 Tat and RAP74 Proteins with the RNA Polymerase II CTD Phosphatase FCP1.
| | Biochemistry, | 44(8):2716-2731, 2005. |
|
|
 |  |  |
Anderson SK, Dewar K, Goulet M-L, Leveque G, Makrigiannis AP
| |
Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype
| |
Genes Immun,
|
6(6):481-492, 2005.
|
|
|
 |  |  | Arnold R, Patzak IM, Neuhaus B, Vancauwenbergh S, Veillette A, Van Lint J, Kiefer F | |
Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1.
| Mol Cell Biol,
| 25(6):2364-2383, 2005.
|
|
|
 |  |  |
Batsché É, Desroches J, Bilodeau S, Gauthier Y, and Drouin J,
| |
Rb enhances 160/SRC coactivator-dependent activity of nuclear receptors and hormone responsiveness.
| |
J Biol Chem,
|
280(20):19746-19756, 2005.
|
|
|
 |  |  |
Bergeron A, Villemure M, Lazure C, Manjunath P
| |
Isolation and characterization of the major proteins of ram seminal plasma.
| |
Mol Reprod Dev,
|
71(4):461-470, 2005.
|
|
|
 |  |  |
Bergeron E, Vincent MJ, Wickham L, Hamelin J, Basak A, Nichol ST, Chrétien M, Seidah NG
| |
Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus.
| |
Biochem Biophys Res Commun,
|
326(3):554-563, 2005.
|
|
|
 |  |  |
Blanchet M, Sheppard R, Racine N, Ducharme A, Curnier D, Tardif JC, Sirois P, Lamoureux MC, de Champlain J, White M
| |
Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
| |
Am Heart J,
|
149(5):e1-e7, 2005.
|
|
|
 |  |  | Bloch-Queyrat C, Fondanèche M-C, Chen R, Yin L, Relouzat F, Veillette A, Fischer A, Latour S | |
Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn.
| | J Exp Med, | 202(1):181-192, 2005. |
|
|
 |  |  |
Bouchard C, Dubuc G, Davignon J, Bernier L, Cohn JS
| |
Post-transcriptional regulation of apoC-I synthesis and secretion in human HepG2 cells.
| |
Atherosclerosis,
|
178(2):257-264, 2005.
|
|
|
 |  |  | Bourgault C, Davignon J, Fodor G, Gagne C, Gaudet D, Genest J, Lavoie MA, Leiter L, McPherson R, Senecal M, Marentette M, Sebaldt RJ | |
Statin therapy in Canadian patients with hypercholesterolemia: The Canadian Lipid Study-- Observational (CALIPSO).
| | Can J Cardiol, | 21(13):1187-1193, 2005. |
|
|
 |  |  | Bouzeghrane F, Reinhardt DP, Reudelhuber TL, Thibault G | |
Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis.
| | Am J Physiol Heart Circ Physiol, | 289(3):H982-H991, 2005. |
|
|
 |  |  |
Braun BR, van Het Hoog M, d'Enfert C, Martchenko M, Dungan J, Kuo A, Inglis DO, Uhl MA, Hogues H, Berriman M, Lorenz M, Levitin A, Oberholzer U, Bachewich C, Harcus D, Marcil A, Dignard D, Iouk T, Zito R, Frangeul L, Tekaia F, Rutherford K, Wang E, Munro CA, Bates S, Gow NA, Hoyer LL, Köhler G, Morschhäuser J, Newport G, Znaidi S, Raymond M, Turcotte B, Sherlock G, Costanzo M, Ihmels J, Berman J, Sanglard D, Agabian N, Mitchell AP, Johnson AD, Whiteway M, Nantel A
| |
A human-curated annotation of the Candida albicans genome.
| |
PLoS Genet,
|
1(1):36-57, 2005.
|
|
|
 |  |  |
Charles MA, Suh H, Hjalt TA, Drouin J, Camper SA, Gage PJ
| |
PITX genes are required for cell survival and Lhx3 activation.
| |
Mol Endocrinol,
|
19(7):1893-1903, 2005.
|
|
|
 |  |  |
Chen H, Chung NN, Lemieux C, Zelent B, Vanderkooi JM, Gryczynski I, Wilkes BC, Schiller PW
| |
[Aladan(3)]TIPP: A fluorescent delta-opioid antagonist with high delta-receptor binding affinity and delta selectivity.
| |
Biopolymers,
|
80(2-3):325-331, 2005.
|
|
|
 |  |  |
Cohen LY, Bourbonnière M, Sabbagh L, Bouchard A, Chew T, Jeannequin P, Lazure C, Sékaly R-P
| |
Notch1 antiapoptotic activity is abrogated by caspase cleavage in dying T lymphocytes.
| |
Cell Death Differ,
|
12(3):243-254, 2005.
|
|
|
 |  |  |
Costa-Mattioli M, Gobert D, Harding H, Herdy B, Azzi M, Bruno M, Bidinosti M, Ben Mamou C, Marcinkiewicz E, Yoshida M, Imataka H, Cuello AC, Seidah N, Sossin W, Lacaille J-C, Ron D, Nader K, Sonenberg N
| |
Translational control of hippocampal synaptic plasticity and memory by the eIF2{alpha} kinase GCN2.
| |
Nature,
|
436(7054):1166-1173, 2005.
|
|
|
 |  |  | D'Amour P, Brossard J-H, Rousseau L, Nguyen-Yamamoto L, Nassif E, Lazure C, Gauthier D, Lavigne JR, Zahradnik RJ | |
Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism.
| Kidney Int,
| 68(3):998-1007, 2005.
|
|
|
 |  |  | Davignon J | |
Apolipoprotein E and atherosclerosis: Beyond lipid effect.
| | Arterioscler Thromb Vasc Biol, | 25(2):267-269, 2005. |
|
|
 |  |  | Davignon J, Leiter LA | |
Ongoing clinical trials of the pleiotropic effects of statins.
| | Vascular Health and Risk Management, | 1(1):29-40, 2005. |
|
|
 |  |  | Davignon J, Verma S, Anderson TJ | | Pleiotropic effects of statins. | | Expert Opinions Clinical Impact, | 1(5):9-12, 2005. |
|
|
 |  |  |
de Champlain J
| | "L'hypertension artérielle est-elle une maladie fréquente?". | |
in : Questions et réponses : mon guide pour maîtriser l'hypertension artérielle. Édité par Denis Drouin, Alain Milot. Montréal : Société québécoise d'hypertension artérielle, 2005. P. 7
|
|
|
 |  |  | Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, Lerman A, Mancia G, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Schiffrin EL, Taddei S, Webb DJ | |
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension.
| | J Hypertens, | 23(1):7-17, 2005. |
|
|
 |  |  | Deschepper CF | | The cardiac antihypertrophic effects of cyclic GMP-generating agents: An experimental framework for novel treatments of left ventricular remodeling. | | Vascular Disease Prevention, | 2(2):151-157, 2005. |
|
|
 |  |  |
Desrosiers M-P, Kielczewska A, Loredo-Osti J-C, Adam SG, Makrigiannis AP, Lemieux S, Pham T, Lodoen MB, Morgan K, Lanier LL, Vidal SM
| |
Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection.
| |
Nat Genet.
|
37(6):593-599, 2005.
|
|
|
 |  |  | Dumais-Roy E, Béliveau L | | Activité physique et impact sur la santé cardiovasculaire. | | Les actualités du coeur, | 9(2):5-7, 2005. |
|
|
 |  |  | EL Midaoui A, Ongali B, Petcu M, Rodi D, de Champlain J, Neugebauer W, Couture R | |
Increases of spinal kinin receptor binding sites in two rat models of insulin resistance.
| | Peptides, | 26(8):1323-1330, 2005. |
|
|
 |  |  | EL Midaoui A, Wu L, de Champlain J | |
Insulin, AGE and hypertension.
| | J Hypertens, | 23(8):1605, 2005. |
|
|
 |  |  | Filip K, Oleszczuk M, Wójcik J, Chung NN, Schiller PW, Pawlak D, Zieleniak A, Parciñska A, Witkowska E, Izdebski J | |
Cyclic enkephalin and dermorphin analogues containing a carbonyl bridge.
| | J Pept Sci, | 11(6):347-352, 2005. |
|
|
 |  |  |
Fontés G, Lajoix AD, Bergeron F, Cadel S, Prat A, Foulon T, Gross R, Dalle S, Le-Nguyen D, Tribillac F, Bataille D
| |
Miniglucagon-generating endopeptidase, which processes glucagon into miniglucagon, is composed of NRD convertase and aminopeptidase B.
| |
Endocrinology,
|
146(2):702-712, 2005.
|
|
|
 |  |  |
Garcia D, Barenbrug PJC, Pibarot P, Dekker ALAJ, van der Veen FH, Maessen JG, Dumesnil JG, Durand L-G
| |
A ventricular-vascular coupling model in presence of aortic stenosis.
| |
Am J Physiol Heart Circ Physiol,
|
288(4):H1874-H1884, 2005.
|
|
|
 |  |  | Garcia D, Kadem L, Pibarot P, Durand L-G | |
Mathematical modeling of coronary inflow in presence of aortic stenosis.
| | Comput Methods Biomech Biomed Engin, | Suppl. 1:111-112, 2005. |
|
|
 |  |  |
Garcia D, Kadem L, Savéry D, Pibarot P, Durand L-G
| |
Explicit analytical models for the aortic transvalvular pressure gradients.
| |
in : Proceedings : 20th Canadian Congress of Applied Mechanics CANCAM 2005, May 30-June 2, 2005 = Comptes rendus : le 20e Congrès canadien de mécanique appliquée. Edited by M.Ostoja-Starzewski. Montréal : McGill University, 2005. P. 126-127.
|
|
|
 |  |  | Gaudreault SB, Blain J-F, Gratton J-P, Poirier J | |
A role for caveolin-1 in post-injury reactive neuronal plasticity.
| | J Neurochem, | 92(4):831-839, 2005. |
|
|
 |  |  |
Genest J
| |
L'homme seul.
| |
Saint-Laurent, Québec : Fidès,
|
2005.
|
|
|
 |  |  |
Groupe de travail du Programme éducatif canadien sur l'hypertension, Touyz RM, de Champlain J, Larochelle P, Schiffrin E
| |
Hypertension: Recommandations canadiennes 2005.
| |
Les actualités du coeur,
|
9(2 Suppl.):1-8, 2005.
|
|
|
 |  |  | He X, He X, Dave VP, Zhang Y, Hua X, Nicolas E, Xu W, Roe BA, Kappes DJ | |
The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.
| | Nature, | 433(7028):826-833, 2005. |
|
|
 |  |  | Hemmelgarn BR, McAlister FA, Myers MG, McKay DW, Bolli P, Abbott C, Schiffrin EL, Grover S, Honos G, Lebel M, Mann K, Wilson T, Penner B, Tremblay G, Tobe SW, Feldman RD | |
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I - Blood pressure measurement, diagnosis and assessment of risk.
| | Can J Cardiol, | 21(8):645-656, 2005. |
|
|
 |  |  | Houde M, Lamarre-Cliche M | | Quels sont les risques de l'hypertension et les bénéfices du traitement? | | in : Questions et réponses : mon guide pour maîtriser l'hypertension artérielle. Édité par Denis Drouin, Alain Milot. Montréal : Société québécoise d'hypertension artérielle, 2005. P. 31-32.
|
|
|
 |  |  | Huber AB, Kania A, Tran TS, Gu C, De Marco Garcia N, Lieberam I, Johnson D, Jessell TM, Ginty DD, Kolodkin AL | |
Distinct roles for secreted semaphorin signaling in spinal motor axon guidance.
| | Neuron, | 48(6):949-964, 2005. |
|
|
 |  |  |
Jin W, Fuki IV, Seidah NG, Benjannet S, Glick JM, and Rader DJ,
| |
Proprotein covertases are responsible for proteolysis and inactivation of endothelial lipase.
| |
J Biol Chem,
|
280(44):36551-36559, 2005.
|
|
|
 |  |  |
Kaczmarek K, Chung NN, Schiller PW
| |
A novel cis-peptide bond motif inducing type VI {beta}-turn. Synthesis and biological evaluation of enkephalin and morphiceptin analogues conformationally restricted at the C-terminus.
| | in : Peptides 2004: Bridges Between Disciplines: Proceedings of the Third International and Twenty-Eighth European Peptide Symposium, September 5-10, 2004 - Prague, Czech Republic. Edited by Martin Flegel, Mati Fridkin, Chaim Gilon, Jirina Slaninova. Geneva, Switzerland : Kenes International, 2005. P. 868-869. |
|
|
 |  |  | Kadem L, Dumesnil JG, Rieu R, Durand L-G, Garcia D, Pibarot P | |
Impact of systemic hypertension on the assessment of aortic stenosis.
| | Heart, | 91(3):354-361, 2005. |
|
|
 |  |  | Kadem L, Knapp Y, Pibarot P, Bertrand E, Durand LG, Rieu R | | A new experimental method for the determination of the effective oriffice area based on the acoustical term source. | | in : Proceedings : 20th Canadian Congress of Applied Mechanics CANCAM 2005, May 30-June 2, 2005 = Comptes rendus : le 20e Congrès canadien de mécanique appliquée. Edited by M.Ostoja-Starzewski. Montréal : McGill University, 2005. P. 214-215. |
|
|
 |  |  |
Kadem L, Knapp Y, Pibarot P, Bertrand E, Garcia D, Durand LG, and Rieu R
| |
A new experimental method for the determination of the effective orifice area based on the acoustical source term.
| |
Experiments in Fluids,
|
39(6):1051-1060, 2005.
|
|
|
 |  |  | Kadem L, Rieu R, Garcia D, Durand LG, Pibarot P | |
Vortex dynamics and aortic valve closure.
| | Comput Methods Biomech Biomed Engin, | Suppl. 1:157-158, 2005. |
|
|
 |  |  | Karas M, Lacourcière Y, LeBlanc A-R, Nadeau R, Dubé B, Florescu M, Lamarre-Cliche M, Poirier L, Larochelle P, de Champlain J |
Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients.
| | J Hypertens, | 23(6):1251-1260, 2005.
|
|
|
 |  |  | Katarzyñska J, Chung NN, Schiller PW, Leplawy MT, Zabrocki J | | Analogues of endomorphin-2 modified with 4-methyl-pseudoproline in position 2. | | in : Peptides 2004: Bridges Between Disciplines: Proceedings of the Third International and Twenty-Eighth European Peptide Symposium, September 5-10, 2004 - Prague, Czech Republic. Edited by Martin Flegel, Mati Fridkin, Chaim Gilon, Jirina Slaninova. Geneva, Switzerland : Kenes International, 2005. P. 982-983. |
|
|
 |  |  | Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, deChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NRC, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD | |
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.
| | Can J Cardiol, | 21(8):657-672, 2005. |
|
|
 |  |  |
Kruszynski R, Fichna J, do-Rego J-C, Chung NN, Schiller PW, Kosson P, Costentin J, Janecka A
| |
Novel endomorphin-2 analogs with {mu}-opioid receptor antagonist activity.
| |
J Pept Res,
|
66(3):125-131, 2005.
|
|
|
 |  |  |
Lalanne F, Lambert G, Amar MJA, Chétiveaux M, Zaïr Y, Jarnoux A-L, Ouguerram K, Friburg J, Seidah NG, Brewer HB, Jr., Krempf M, and Costet P,
| |
Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells.
| |
J Lipid Res,
|
46(6):1312-1319, 2005.
|
|
|
 |  |  | Larochelle P | |
From the Canadian Hypertension Society.
| | Hypertension News: An Electronic Newsletter, | Opus 7, 2005. |
|
|
 |  |  | Larochelle P | | Quelles sont les valeurs de la pression artérielle à retenir? | | in : Questions et réponses : mon guide pour maîtriser l'hypertension artérielle. Édité par Denis Drouin, Alain Milot. Montréal : Société québécoise d'hypertension artérielle, 2005. P. 19-21.
|
|
|
 |  |  | Llamas B, Contesse V, Guyonnet-Duperat V, Vaudry H, Mormède P, Moisan M-P | |
QTL mapping for traits associated with stress neuroendocrine reactivity in rats.
| | Mamm Genome, | 16(7):505-515, 2005. |
|
|
 |  |  |
Nagashima K, Lopez C, Donovan D, Ngai C, Fontanez N, Bensadoun A, Fruchart-Najib J, Holleran S, Cohn JS, Ramakrishnan R, Ginsberg HN
| |
Effects of the PPAR{gamma} agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes.
| |
J Clin Invest,
|
115(5):1323-1332, 2005
|
|
|
 |  |  |
Pilorget A, Annabi B, Bouzeghrane F, Marvaldi J, Luis J, Béliveau R
| |
Inhibition of angiogenic properties of brain endothelial cells by platelet-derived sphingosine-1-phosphate.
| |
J Cereb Blood Flow Metab,
|
25(9):1171-1182, 2005.
|
|
|
 |  |  |
Pladys P, Sennlaub F, Brault S, Checchin D, Lahaie I, Lê NLO, Bibeau K, Cambonie G, Abran D, Brochu M, Thibault G, Hardy P, Chemtob S, Nuyt AM
| |
Microvascular rarefaction and decreased angiogenesis in rats with fetal programming of hypertension associated with exposure to a low protein diet in utero.
| |
Am J Physiol Regul Integr Comp Physiol,
|
289(6):R1580-R1588, 2005.
|
|
|
 |  |  | Priceputu E, Rodrigue I, Chrobak P, Poudrier J, Mak TW, Hanna Z, Hu C, Kay DG, Jolicoeur P | |
The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1{beta}-converting enzyme-deficient or Bcl2-expressing transgenic mice.
| | J Virol, | 79(10):6377-6391, 2005. |
|
|
 |  |  | René C, Taulan M, Iral F, Doudement J, L'Honoré A, Gerbon C, Demaille J, Claustres M, Romey M-C | |
Binding of serum response factor to cystic fibrosis transmembrane conductance regulator CArG-like elements, as a new potential CFTR transcriptional regulation pathway.
| | Nucleic Acids Res, | 33(16):5271-5290, 2005. |
|
|
 |  |  |
Roncagalli R, Taylor JER, Zhang S, Shi X, Chen R, Cruz-Munoz M-E, Yin L, Latour S, and Veillette A,
| |
Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor.
| |
Nat.Immunol.
|
6(10):1002-1010, 2005.
|
|
|
 |  |  | Roy DJ | | Ethics in palliative care research. | | in : Palliative Medicine : A Case-Based Manual. Edited by Neil MacDonald, Doreen Oneschuk, Neil Hagen, Derek Doyle. 2nd ed. Oxford, UK : Oxford University Press, 2005. P. 261-269. |
|
|
 |  |  | Roy DJ | | Late words to a dying man. | | J Palliat Care, | 21(4):235-237, 2005. |
|
|
 |  |  | Roy DJ | | On questions no one can answer. | | J Palliat Care, | 21(1):3-4, 2005. |
|
|
 |  |  | Roy DJ | | Songs of palliative care? | | J Palliat Care, | 21(2):67-68, 2005. |
|
|
 |  |  | Roy DJ | | Palliative care without borders. | | J Palliat Care, | 21(3):131-132, 2005. |
|
|
 |  |  |
Ruel IL, Lamarche B, Mauger J-F, Badellino KO, Cohn JS, Marcil M, Couture P
| |
Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency.
| |
Arterioscler Thromb Vasc Biol,
|
25(12):2600-2607, 2005.
|
|
|
 |  |  |
Salvas A, Benjannet S, Reudelhuber TL, Chrétien M, and Seidah NG
| |
Evidence for proprotein convertase activity in the endoplasmic reticulum/early Golgi.
| |
FEBS Lett,
|
579(25):5621-5625, 2005.
|
|
|
 |  |  |
Schiffrin EL
| |
Vascular endothelin in hypertension.
| |
Vasc Pharmacol,
|
43(1):19-29, 2005.
|
|
|
 |  |  |
Schiller PW
| |
Current trends in the development of opioid analgesics.
| |
AAPS Newsmagazine,
|
8(7):18-20, 2005.
|
|
|
 |  |  |
Schiller PW
| |
Opioid peptide-derived analgesics.
| |
AAPS Journal,
|
7(3):E560-E565, 2005.
|
|
|
 |  |  |
Shachter NS, Rabinowitz D, Stohl S, Conde-Knape K, Cohn JS, Deckelbaum RJ, Berglund L, Shea S
| |
The common insertional polymorphism in the APOC1 promoter is associated with serum apolipoprotein C-I levels in Hispanic children.
| |
Atherosclerosis,
|
179(2):387-393, 2005.
|
|
|
 |  |  |
Shimoyama M, Kuwaki T, Nakamura A, Fukuda Y, Shimoyama N, Schiller PW, Szeto HH
| |
Differential respiratory effects of [Dmt1]DALDA and morphine in mice.
| |
Eur J Pharmacol,
|
511(2-3):199-206, 2005.
|
|
|
 |  |  |
Siegfried G, Basak A, Prichett-Pejic W, Scamuffa N, Ma L, Benjannet S, Veinot JP, Calvo F, Seidah N, Khatib A-M
| |
Regulation of the stepwise proteolytic cleavage and secretion of PDGF-B by the proprotein convertases.
| |
Oncogene,
|
24(46):6925-6935, 2005.
|
|
|
 |  |  |
Stawowy P, Kallisch H, Borges Pereira Stawowy N, Stibenz D, Veinot JP, Gräfe M, Seidah NG, Chrétien M, Fleck E, Graf K
| |
Immunohistochemical localization of subtilisin/kexin-like proprotein convertases in human atherosclerosis.
| |
Virchows Arch,
|
446(4):351-359, 2005.
|
|
|
 |  |  |
Stawowy P, Meyborg H, Stibenz D, Stawowy NBP, Roser M, Thanabalasingam U, Veinot JP, Chrétien M, Seidah NG, Fleck E, Graf K
| |
Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis.
| |
Circulation,
|
111(21):2820-2827, 2005.
|
|
|
 |  |  |
Takeuchi JK, Mileikovskaia M, Koshiba-Takeuchi K, Heidt AB, Mori AD, Arruda EP, Gertsenstein M, Georges R, Davidson L, Mo R, Hui CC, Henkelman RM, Nemer M, Black BL, Nagy A, Bruneau BG
| |
Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development.
| |
Development,
|
132(10):2463-2474, 2005.
|
|
|
 |  |  |
Touyz RM, Mercure C, He Y, Javeshghani D, Yao G, Callera GE, Yogi A, Lochard N, Reudelhuber TL
| |
Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.
| |
Hypertension,
|
45(4):530-537, 2005.
|
|
|
 |  |  | Touyz RM, Moreau P | | Des changements aux habitudes de vie peuvent-ils prévenir ou atténuer l'hypertension? | | in : Questions et réponses : mon guide pour maîtriser l'hypertension artérielle. Édité par Denis Drouin, Alain Milot. Montréal : Société québécoise d'hypertension artérielle, 2005. P. 35-37. |
|
|
 |  |  |
Tryoen-Tóth P, Décaillot FM, Filliol D, Befort K, Lazarus LH, Schiller PW, Schmidhammer H, Kieffer BL
| |
Inverse agonism and neutral antagonism at wild-type and constitutively active mutant delta opioid receptors.
| |
J Pharmacol Exp Ther,
|
313(1):410-421, 2005.
|
|
|
 |  |  | Tzimas GN, Chevet E, Jenna S, Nguyen DT, Khatib AM, Marcus V, Zhang Y, Chretien M, Seidah N, Metrakos P | |
Abnormal expression and processing of the proprotein convertases PC1 and PC2 in human colorectal liver metastases.
| | BMC Cancer, | 5(1):149, 2005. |
|
|
 |  |  |
Vallette-Kasic S, Brue T, Pulichino A-M, Gueydan M, Barlier A, David M, Nicolino M, Malpuech G, Déchelotte P, Deal C, Van Vliet G, De Vroede M, Riepe FG, Partsch C-J, Sippell WG, Berberoglu M, Atasay B, de Zegher F, Beckers D, Kyllo J, Donohoue P, Fassnacht M, Hahner S, Allolio B, Noordam C, Dunkel L, Hero M, Pigeon B, Weill J, Yigit S, Brauner R, Heinrich JJ, Cummins E, Riddell C, Enjalbert A, Drouin J
| |
Congenital isolated adrenocorticotropin deficiency: An underestimated cause of neonatal death, explained by TPIT mutations.
| |
J Clin Endocrinol Metab,
|
90(3):1323-1331, 2005.
|
|
|
 |  |  |
Van den Eynde I, Laus G, Schiller PW, Kosson P, Chung NN, Lipkowski AJ, Tourwé D
| |
A new structural motif for {mu}-opioid antagonists.
| |
J Med Chem,
|
48(10):3644-3648, 2005.
|
|
|
 |  |  | Van den Eynde I, Tourwé D, Kosson P, Lipkowski AJW, Chung NN, Schiller PW | | Novel modifications of he Dmt-Tic pharmacophore provide new peptidomimetic {mu}-opioid antagonists. | | in : Peptides 2004: Bridges Between Disciplines: Proceedings of the Third International and Twenty-Eighth European Peptide Symposium, September 5-10, 2004 - Prague, Czech Republic. Edited by Martin Flegel, Mati Fridkin, Chaim Gilon, Jirina Slaninova. Geneva, Switzerland : Kenes International, 2005. P. 958-959. |
|
|
 |  |  | Wang J, Paradis P, Aries A, Komati H, Lefebvre C, Wang H, Nemer M | |
Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4.
| Mol Cell Biol,
| 25(22):9829-9844, 2005.
|
|
|
 |  |  | Weltrowska G, Lemieux C, Chung NN, Schiller PW | | Replacement of the Tyr1 hydroxyl group in a cyclic enkephalin analogue with various substituents results in potent opioid agonists. | | in : Peptides 2004: Bridges Between Disciplines: Proceedings of the Third International and Twenty-Eighth European Peptide Symposium, September 5-10, 2004 - Prague, Czech Republic. Edited by Martin Flegel, Mati Fridkin, Chaim Gilon, Jirina Slaninova. Geneva, Switzerland : Kenes International, 2005. P. 978-979. |
|
|
 |  |  |
Yokoyama H, Averill DB, Brosnihan KB, Smith RD, Schiffrin EL, Ferrario CM
| |
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
| |
Am J Hypertens,
|
18(7):922-929, 2005.
|
|
|
 |  |  |
Žigman M, Cayouette M, Charalambous C, Schleiffer A, Hoeller O, Dunican D, McCudden CR, Firnberg N, Barres BA, Siderovski DP, Knoblich JA
| |
Mammalian inscuteable regulates spindle orientation and cell fate in the developing retina.
| |
Neuron,
|
48(4):539-545, 2005.
|
|
|
|